Ad-hoc | 22 May 2002 09:38

aap Implantate AG english

aap Implantate AG: Interim Q1 2002 figures Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– aap Implantate AG: Interim Q1 2002 figures 15% growth in sales revenues / EBITDA increase ex stock option 118% / Turnaround already achieved / Restructuring program shows clear successes aap Implantate AG, the metal and biological implant specialist for the muscular- skeletal system, increased sales revenues in the first quarter of 2002 by roughly 15% on the year to approximately EUR 3.42 million from EUR 2.98 million. EBITDA excluding stock options was up roughly 118% to roughly EUR 1.2 million (previous: EUR 540,000). Not counting acquisition-related depreciations totaling EUR 365,000 (previous: EUR 403,000) and stock options totaling EUR 170,000 (previous: EUR 208,000), EBIT amounted to EUR 895,000 (previous: EUR 232,000). Including the above-mentioned special effects (stock options and acquisition- related depreciations), EBIT was EUR 361,000 (previous: -EUR 379,000). The figures reconfirm the previously stated outlook for 2002 of double-digit growth in sales revenues and a net profit for the year without the above- mentioned special effects. aap Implantate AG will be announcing detailed figures on May 31 when the 3 monthly report is published. end of ad-hoc-announcement (c)DGAP 22.05.2002 ——————————————————————————– WKN: 506660; ISIN: DE0005066609; Index: Listed: Neuer Markt Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 220938 Mai 02